Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Wegovy can cause body aches in some people. Musculoskeletal discomfort, including generalised achiness and muscle pain, appears in the clinical trial data for semaglutide, and a proportion of people starting treatment or moving to a higher dose do notice it. It is not among the most common side effects, but it is real, and it is worth knowing what to expect. As with all prescription medicines, suitability needs to be assessed by a prescriber — Wegovy is a prescription-only medicine available only after a clinical review.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Imagine this: you started Wegovy three or four weeks ago, you are eating less without much effort, and then you notice a low-level achiness settling into your legs or lower back. You are not unwell in any obvious way. You just feel a bit beaten up. A question our prescribers hear most weeks is some version of this, "I expected nausea, but why do I ache?"
It is a fair question. The registered side-effect profile for semaglutide 2.4mg, the active ingredient in Wegovy, does include musculoskeletal complaints. Back pain and pain in the limbs appear in the clinical trial data. They tend to sit in the "common" or "uncommon" category rather than dominating the experience the way gastrointestinal symptoms do (nausea, for instance, affects considerably more people) but they are documented.
The most likely explanation involves several things happening at once. Food intake drops, sometimes sharply, in the first weeks of treatment. Caloric restriction on its own can temporarily cause fatigue and mild achiness as the body adjusts its energy use. At the same time, some people increase their activity because they feel more motivated, and muscles that have not been worked hard recently push back. Hydration can also slip without people realising it, and inadequate fluid intake has its own aching consequences. None of this means something is wrong with the medicine itself; it reflects the body recalibrating. If you want a thorough answer to whether Wegovy can make your body ache, including how people have managed it in practice, that page covers the full picture.
Most body aches reported during Wegovy treatment are diffuse, low-level and self-limiting, and our page on body aches on Wegovy gives a detailed breakdown of what people actually experience and how those sensations tend to evolve over time. Our page on Wegovy and leg aches specifically goes into more detail if that is the area bothering you most.
There are situations, though, where aching changes character and needs prompt attention. Severe stomach pain that radiates to the back (with or without vomiting) is not something to wait out. The MHRA issued a Yellow Card Drug Safety Update in January 2026 highlighting acute pancreatitis as an infrequent but serious side effect of GLP-1 medicines including semaglutide. The symptom pattern for pancreatitis overlaps with other abdominal issues, which is exactly why severe, persistent stomach-to-back pain needs same-day medical assessment rather than reassurance from a side-effect article.
Similarly, chest pain, pronounced muscle weakness, or aching accompanied by dark urine, swelling in the limbs, or breathlessness are outside the expected profile and should be reported to a doctor or, if severe, to emergency services. Suspected side effects from any medicine can be submitted directly to the MHRA via the Yellow Card scheme.
For the more typical, background-level achiness that comes with early treatment, a few practical steps are commonly suggested. Staying well hydrated matters more than it sounds, semaglutide slows gastric emptying, meals are smaller, and people do not always drink enough to compensate. If activity has increased alongside starting treatment, that is positive but the timing matters; ramping up too fast on a reduced calorie intake can leave muscles under-recovered.
Protein intake is another factor worth keeping an eye on. When overall food volume drops, protein is sometimes the casualty, and muscle tissue without adequate protein support is more prone to aching and loss. The NHS patient information for semaglutide and the Patient Information Leaflet supplied with your medication both cover what to expect and when to seek help, reading them is genuinely useful, not just a formality.
If aching is consistently disrupting sleep or daily life, that is worth raising with whoever prescribed your treatment. A prescriber can look at the full picture: whether the dose increase timeline is appropriate for your tolerance, whether there is anything in your medical history contributing, and whether the aching is likely to be treatment-related at all. Slowing the titration schedule is sometimes the right clinical decision; that is not a failure, it is the process working as intended.
For a broader understanding of whether Wegovy causes muscle aches specifically, and how that sits alongside the general body-ache picture, that page covers the muscle side of things in more depth. And if you want to understand what Wegovy does to your body more broadly, including the physical adjustments people navigate in the first month, our first-month Wegovy guide sets realistic expectations from the start.
Wegovy is a prescription-only medicine. If you are thinking about starting treatment and want to understand whether it might suit your circumstances, starting a free consultation with our prescribers is the right first step, they can review your health history and discuss what to expect honestly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.